Mc David Stilwell is Chief Financial Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 75,305 shares of CHRS, which is worth approximately $114,463. The most recent transaction as insider was on Dec 31, 2023, when has been sold 18,440 shares (Common Stock) at a price of $3.33 per share, resulting in proceeds of $61,405. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.3K
0% 3M change
26.35% 12M change
Total Value Held $114,463

McDavid Stilwell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2023
SELL
Payment of exercise price or tax liability
$61,405 $3.33 p/Share
18,440 Reduced 19.67%
75,305 Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$23,645 $6.84 p/Share
3,457 Reduced 3.27%
102,252 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 27.73%
104,243 Common Stock
Jan 04 2023
SELL
Payment of exercise price or tax liability
$53,663 $9.87 p/Share
5,437 Reduced 7.8%
64,243 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$44,435 $12.85 p/Share
3,458 Reduced 4.73%
69,680 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 35.36%
73,138 Common Stock
Oct 15 2021
SELL
Open market or private sale
$58,918 $16.8 p/Share
3,507 Reduced 9.99%
31,611 Common Stock
Jun 09 2021
BUY
Open market or private purchase
$49,654 $13.42 p/Share
3,700 Added 9.53%
35,118 Common Stock
Apr 28 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 40.0%
30,000 Common Stock
MS

Mc David Stilwell

Chief Financial Officer
Redwood City, CA

Track Institutional and Insider Activities on CHRS

Follow Coherus BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS